Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study - UTU Research Portal

A1 Refereed original research article in a scientific journal

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study

Authors: Pär Stattin, Andrew J. Vickers, Daniel D. Sjoberg, Robert Johansson, Torvald Granfors, Mattias Johansson, Kim Pettersson, Peter T. Scardino, Göran Hallmans, Hans Lilja

Publisher: ELSEVIER SCIENCE BV

Publication year: 2015

Journal: European Urology

Journal name in source: EUROPEAN UROLOGY

Journal acronym: EUR UROL

Volume: 68

Issue: 2

First page : 207

Last page: 213

Number of pages: 7

ISSN: 0302-2838

DOI: https://doi.org/10.1016/j.eururo.2015.01.009

Abstract

Patient summary: For men in their fifties, screening should focus on those in the top 10% to 25% of PSA values because the majority of subsequent cases of distant metastasis are found among these men. Testing of four kallikrein markers in men with an elevated PSA could aid biopsy decision making. (C) 2015 European Association of Urology. Published by Elsevier B.V.